The editorial handling of manuscripts submitted to Revista Médica de Chile

Revista médica de Chile
Humberto ReyesMax Andresen

Abstract

This Editorial describes the steps followed by a manuscript when it is submitted to Revista Médica de Chile: its reception, format checking as requested in Instructions to Authors, and the editors' decision whether it is considered suitable for the purposes of this journal or not; the selection of peer reviewers, a direct contact with them to ask for their willingness to review this particular manuscript; an analysis by the editors of the reviewers' criticisms leading them to the decision of whether to accept it in the current version, or to return it to the authors with a request to prepare a new corrected version, or a definitive rejection; the editors' review of a corrected version (that may require again the opinion of the external reviewers) and the final decision to accept it or not; printing of the manuscript, two successive galley proofs reviewed by authors and editors; and the final printing of the journal with its simultaneous reproduction in the web page www.scielo.cl. Roughly 70% of the manuscripts are returned to the authors offering them the opportunity to resubmit a corrected version, 12% are definitively rejected and 20% are accepted in their first version. The mean time taken for an accepted manuscript since it...Continue Reading

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.